Image

Study of the Aliviado DSD Caregiving Mastery Program

Study of the Aliviado DSD Caregiving Mastery Program

Non Recruiting
18 years and older
All
Phase N/A

Powered by AI

Overview

Delirium superimposed on dementia (DSD) is an acute and serious condition that is common in persons living with dementia (PLWD). Involvement of family caregivers may aid prevention, early detection, and management of DSD. The purpose of the proposed study is two-fold. First, the investigators will develop a family-centered, mHealth-enhanced DSD caregiving mastery program ("Aliviado DSD Caregiving Mastery Program") through a 5-week co-design workshop with 8 family caregivers (Aim 1). The investigators will adapt/refine the existing clinician-centered DSD contents and an mHealth app from the evidence-based "Aliviado Dementia Care" program for use by family caregivers to support their day-to-day implementation of DSD detection, prevention, and management tasks in the community. Second, the investigators will pilot test the full Aliviado DSD Caregiving Mastery Program with 30 family caregivers of PLWD at high risk for delirium, assessing feasibility, acceptability, app usability, and preliminary program impact (Aim 2).

Eligibility

Inclusion Criteria:

To be eligible as a "dementia caregiver" in the co-design workshop, an individual must:

  • be at least 18 years old,
  • be English-speaking,
  • provide at least 8 hours of unpaid care weekly or live with a community-dwelling PLWD,
  • self-identify as unfamiliar with DSD,
  • have the capacity to consent, and
  • have Internet access

To be eligible as a "DSD caregiver" in the co-design workshop, an individual must:

  • be at least 18 years old,
  • be English-speaking,
  • be a current or past dementia caregiver with experience caring for a relative or friend during his/her DSD episode within the past 12 months,
  • have the capacity to consent, and
  • have Internet access.
        To be eligible to participate in the feasibility trial, an individual must meet all of the
        following criteria:
          -  Being 18 years old or older,
          -  English-speaking,
          -  Providing at least 8 hours of unpaid care per week to, or living with, a community
             dwelling PLWD whose Delirium Risk Assessment Score >=5,
          -  Having the capacity to give informed consent, and
          -  Having a smartphone with Internet access.
        Exclusion Criteria:
          -  Individuals who are blind or deaf will be excluded.

Study details
    Delirium Superimposed on Dementia

NCT05630014

NYU Langone Health

20 August 2025

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.